Oxford Nanopore Technologies

Overview

Oxford Nanopore Technologies, based in the United Kingdom and founded in 2005, operates within the manufacturing sector, specifically focusing on test and measurement equipment for research and clinical applications. The company specializes in nanopore sequencing technology, which allows for the analysis of large cohorts of clinical research samples, facilitating advancements in understanding disease mechanisms and the identification of novel biomarkers. Their published documents highlight the importance of whole-genome sequencing, particularly in underrepresented populations, and emphasize the capability of their PromethION™ 24 device to perform real-time sequencing and data analysis. This technology enables the capture of various genomic and epigenomic variants, including single nucleotide variants, structural variants, and methylation, all within a single sequencing run. The company provides detailed guidance on sample preparation and extraction protocols to ensure high-quality sequencing results, thus supporting researchers in their efforts to conduct comprehensive genomic studies. Through these contributions, Oxford Nanopore Technologies aims to enhance the efficiency and effectiveness of clinical and cancer research.

Industry